دورية أكاديمية
Does the sympathetic nervous system contribute to the pathophysiology of metabolic syndrome?
| العنوان: | Does the sympathetic nervous system contribute to the pathophysiology of metabolic syndrome? |
|---|---|
| المؤلفون: | Moreira MC; Department of Physiological Sciences, Center for Neuroscience and Cardiovascular Research, Federal University of Goiás Goiânia, Brazil., Pinto IS; Department of Physiological Sciences, Center for Neuroscience and Cardiovascular Research, Federal University of Goiás Goiânia, Brazil., Mourão AA; Department of Physiological Sciences, Center for Neuroscience and Cardiovascular Research, Federal University of Goiás Goiânia, Brazil., Fajemiroye JO; Laboratory of Pharmacology of Natural Products, Federal University of Goiás Goiânia, Brazil., Colombari E; Department of Physiology and Pathology, School of Dentistry, Universidade Estadual Paulista Araraquara, Brazil., Reis ÂA; Department of Biochemistry and Molecular Biology, Federal University of Goiás Goiânia, Brazil., Freiria-Oliveira AH; Department of Physiological Sciences, Center for Neuroscience and Cardiovascular Research, Federal University of Goiás Goiânia, Brazil., Ferreira-Neto ML; Laboratory of Experimental Physiology, Faculty of Physical Education, Federal University of Uberlândia Uberlândia, Brazil., Pedrino GR; Department of Physiological Sciences, Center for Neuroscience and Cardiovascular Research, Federal University of Goiás Goiânia, Brazil. |
| المصدر: | Frontiers in physiology [Front Physiol] 2015 Aug 25; Vol. 6, pp. 234. Date of Electronic Publication: 2015 Aug 25 (Print Publication: 2015). |
| نوع المنشور: | Journal Article; Review |
| اللغة: | English |
| بيانات الدورية: | Publisher: Frontiers Research Foundation Country of Publication: Switzerland NLM ID: 101549006 Publication Model: eCollection Cited Medium: Print ISSN: 1664-042X (Print) Linking ISSN: 1664042X NLM ISO Abbreviation: Front Physiol Subsets: PubMed not MEDLINE |
| أسماء مطبوعة: | Original Publication: Lausanne : Frontiers Research Foundation |
| مستخلص: | The metabolic syndrome (MS), formally known as syndrome X, is a clustering of several risk factors such as obesity, hypertension, insulin resistance, and dislypidemia which could lead to the development of diabetes and cardiovascular diseases (CVD). The frequent changes in the definition and diagnostic criteria of MS are indications of the controversy and the challenges surrounding the understanding of this syndrome among researchers. Obesity and insulin resistance are leading risk factors of MS. Moreover, obesity and hypertension are closely associated to the increase and aggravation of oxidative stress. The recommended treatment of MS frequently involves change of lifestyles to prevent weight gain. MS is not only an important screening tool for the identification of individuals at high risk of CVD and diabetes but also an indicator of suitable treatment. As sympathetic disturbances and oxidative stress are often associated with obesity and hypertension, the present review summarizes the role of sympathetic nervous system and oxidative stress in the MS. |
| References: | Prog Brain Res. 1996;107:127-44. (PMID: 8782517) Hypertension. 1986 Apr;8(4):344-8. (PMID: 2870025) Hypertension. 1998 Jan;31(1 Pt 2):409-14. (PMID: 9453337) Arterioscler Thromb Vasc Biol. 2006 Jun;26(6):1215-25. (PMID: 16543495) PLoS One. 2014 Jun 02;9(6):e94129. (PMID: 24887437) Metabolism. 2003 Nov;52(11):1426-32. (PMID: 14624401) Nutr Metab Cardiovasc Dis. 2005 Dec;15(6):441-9. (PMID: 16314230) Diabet Med. 1998 Jul;15(7):539-53. (PMID: 9686693) Diabetes Care. 1991 Jun;14(6):470-87. (PMID: 1864220) Am J Cardiol. 2007 Feb 19;99(4A):15B-26B. (PMID: 17307055) Br J Nutr. 2014 Dec 28;112(12):1923-32. (PMID: 25347215) Diabetes Obes Metab. 2007 May;9(3):350-3. (PMID: 17391162) Hypertension. 2003 Feb;41(2):249-54. (PMID: 12574090) Endocr Pract. 2003 May-Jun;9(3):237-52. (PMID: 12924350) Am J Physiol Heart Circ Physiol. 2007 Dec;293(6):H3301-10. (PMID: 17873027) Int J Mol Med. 1999 Sep;4(3):223-30. (PMID: 10425270) Popul Health Metr. 2015 Jan 24;13:1. (PMID: 25745363) Annu Rev Immunol. 2003;21:335-76. (PMID: 12524386) Nutr Rev. 2002 Oct;60(10 Pt 2):S47-55; discussion S68-84, 85-7. (PMID: 12403084) J Intern Med. 2007 Oct;262(4):408-14. (PMID: 17875176) Arterioscler Thromb Vasc Biol. 2000 Oct;20(10):2243-7. (PMID: 11031210) Am J Cardiol. 2003 Aug 18;92(4A):3J-9J. (PMID: 12957321) Cell Mol Neurobiol. 2003 Oct;23(4-5):739-49. (PMID: 14514028) Am J Hypertens. 2003 Nov;16(11 Pt 1):952-8. (PMID: 14573334) Circulation. 2000 Jul 4;102(1):42-7. (PMID: 10880413) Circulation. 2002 Mar 26;105(12):1503-8. (PMID: 11914262) Arterioscler Thromb Vasc Biol. 2003 Mar 1;23(3):434-9. (PMID: 12615693) J Am Coll Cardiol. 2008 Oct 7;52(15):1201-10. (PMID: 18926322) Br J Pharmacol. 1996 Dec;119(8):1635-41. (PMID: 8982512) J Hypertens. 2006 Jan;24(1):47-9. (PMID: 16331100) Circulation. 2004 Jan 27;109(3):433-8. (PMID: 14744958) Eur J Vasc Endovasc Surg. 2007 Jul;34(1):18-22. (PMID: 17296319) J Clin Invest. 2006 Nov;116(11):3015-25. (PMID: 17053832) Diabetes Metab J. 2015 Feb;39(1):66-73. (PMID: 25729715) Nat Rev Neurosci. 2006 May;7(5):335-46. (PMID: 16760914) Obesity (Silver Spring). 2007 Jul;15(7):1685-93. (PMID: 17636086) Hypertension. 2000 Oct;36(4):538-42. (PMID: 11040232) Circ Res. 2007 Jun 8;100(11):1589-96. (PMID: 17478729) J Hypertens. 2007 Dec;25(12):2471-8. (PMID: 17984669) Arq Bras Endocrinol Metabol. 2008 Apr;52(3):537-49. (PMID: 18506280) Diabetologia. 2006 Jun;49(6):1169-74. (PMID: 16570157) Braz J Med Biol Res. 2000 Jun;33(6):605-18. (PMID: 10829088) J Hum Hypertens. 2012 Aug;26(8):463-75. (PMID: 21734720) Circ Res. 1992 Apr;70(4):660-9. (PMID: 1551193) Int J Epidemiol. 2003 Aug;32(4):600-6. (PMID: 12913036) J Am Coll Cardiol. 2005 Dec 6;46(11):1978-85. (PMID: 16325028) Am J Hypertens. 1989 Mar;2(3 Pt 2):125S-132S. (PMID: 2647103) Clin Exp Pharmacol Physiol. 2010 Nov;37(11):1035-43. (PMID: 20659132) Cardiovasc Res. 1998 Mar;37(3):772-9. (PMID: 9659462) J Diabetes Res. 2015;2015:341583. (PMID: 26064978) Hypertension. 1992 Jan;19(1 Suppl):I67-77. (PMID: 1730457) J Hypertens. 2007 May;25(5):909-20. (PMID: 17414649) Can J Physiol Pharmacol. 2012 Aug;90(8):1029-59. (PMID: 22646022) Diab Vasc Dis Res. 2011 Apr;8(2):109-16. (PMID: 21562062) Int J Obes Relat Metab Disord. 1998 Dec;22(12):1145-58. (PMID: 9877249) Maedica (Buchar). 2014 Sep;9(3):255-60. (PMID: 25705287) Hypertension. 1999 Oct;34(4 Pt 1):539-45. (PMID: 10523323) Clin Exp Hypertens. 2001 Jan-Feb;23(1-2):45-55. (PMID: 11270588) Circulation. 2001 Jan 30;103(4):513-9. (PMID: 11157715) Diabetologia. 1997 Feb;40(2):125-35. (PMID: 9049471) Stroke. 2015 May;46(5):e121-2. (PMID: 25873596) Hypertension. 2002 Feb;39(2 Pt 2):597-602. (PMID: 11882615) Nutr Metab Cardiovasc Dis. 2008 Jan;18(1):31-8. (PMID: 17420118) Hypertension. 1995 Apr;25(4 Pt 2):893-7. (PMID: 7721450) Am J Physiol Endocrinol Metab. 2001 May;280(5):E745-51. (PMID: 11287357) Med Sci Sports Exerc. 2003 Aug;35(8):1279-86. (PMID: 12900679) J Hum Hypertens. 2008 Jan;22(1):4-11. (PMID: 17823599) Hypertension. 1998 Jan;31(1 Pt 2):266-70. (PMID: 9453314) Front Immunol. 2014 Dec 04;5:620. (PMID: 25538705) Arterioscler Thromb Vasc Biol. 2005 Jun;25(6):1268-73. (PMID: 15790931) N Engl J Med. 2001 Jan 4;344(1):3-10. (PMID: 11136953) Circulation. 2002 Mar 5;105(9):1135-43. (PMID: 11877368) Mol Cell Biol. 1992 Apr;12(4):1789-97. (PMID: 1372389) Arq Bras Cardiol. 2006 Oct;87(4):538-47. (PMID: 17128327) Am J Hypertens. 1997 Jul;10(7 Pt 1):720-7. (PMID: 9234825) Regul Pept. 2000 Aug 25;92(1-3):51-6. (PMID: 11024565) N Engl J Med. 1989 Aug 31;321(9):580-5. (PMID: 2668763) Cytokine Growth Factor Rev. 2003 Oct;14(5):447-55. (PMID: 12948526) Hypertension. 2002 Oct;40(4):504-10. (PMID: 12364354) Toxicol Res. 2014 Sep;30(3):141-8. (PMID: 25343007) Pharm Acta Helv. 1998 Jun;73(1):27-35. (PMID: 9708036) Ann Epidemiol. 2003 Nov;13(10):674-82. (PMID: 14599731) Pediatr Res. 2004 Dec;56(6):842-8. (PMID: 15470199) Mol Cell Biochem. 2011 Jun;352(1-2):99-108. (PMID: 21318349) J Biol Chem. 2007 Nov 30;282(48):35279-92. (PMID: 17916553) Circulation. 1998 May 26;97(20):2037-42. (PMID: 9610534) Clin Exp Pharmacol Physiol. 2002 Apr;29(4):261-8. (PMID: 11985533) Exp Physiol. 2008 May;93(5):589-98. (PMID: 18448664) Clinics (Sao Paulo). 2006 Oct;61(5):433-40. (PMID: 17072441) Cardiol Res Pract. 2014;2014:943162. (PMID: 24711954) Nephrol Dial Transplant. 2007 Apr;22(4):992-5. (PMID: 17210585) Curr Opin Clin Nutr Metab Care. 2005 Jul;8(4):347-54. (PMID: 15930956) Compr Physiol. 2013 Jan;3(1):1-58. (PMID: 23720280) Circulation. 2002 Nov 19;106(21):2659-65. (PMID: 12438290) Ann N Y Acad Sci. 2006 Nov;1083:129-52. (PMID: 17148737) Front Immunol. 2015 Jan 22;5:683. (PMID: 25657646) Eur Heart J. 2001 Jul;22(13):1082-101. (PMID: 11428849) Am J Physiol. 1999 Jun;276(6 Pt 2):R1600-7. (PMID: 10362737) J Clin Invest. 2004 Dec;114(12):1752-61. (PMID: 15599400) Curr Hypertens Rev. 2010 May 1;6(2):104-209. (PMID: 21562617) Life Sci. 2004 Apr 30;74(24):2987-3000. (PMID: 15051422) J Clin Invest. 1997 Jul 15;100(2):270-8. (PMID: 9218503) Physiol Rev. 1994 Apr;74(2):323-64. (PMID: 8171117) Am J Hypertens. 2001 Nov;14(11 Pt 2):304S-309S. (PMID: 11721888) J Clin Invest. 1994 May;93(5):2267-74. (PMID: 8182160) Hypertension. 1991 Apr;17(4 Suppl):III29-35. (PMID: 2013490) Am J Physiol Regul Integr Comp Physiol. 2013 Sep 15;305(6):R566-81. (PMID: 23883674) Hypertension. 2011 Jun;57(6):1026-33. (PMID: 21536990) J Clin Endocrinol Metab. 2003 Jun;88(6):2399-403. (PMID: 12788834) Hypertension. 1995 Apr;25(4 Pt 1):560-3. (PMID: 7721398) Clin Chim Acta. 2006 Apr;366(1-2):74-80. (PMID: 16343470) Curr Hypertens Rep. 2014 Sep;16(9):466. (PMID: 25090962) Am J Physiol Cell Physiol. 2007 Nov;293(5):C1481-8. (PMID: 17728393) Arteriosclerosis. 1990 Mar-Apr;10(2):223-31. (PMID: 2180396) Nutr Metab Cardiovasc Dis. 2007 Jul;17(6):473-81. (PMID: 17451923) Obesity (Silver Spring). 2006 Dec;14(12):2127-31. (PMID: 17189537) Clin Chim Acta. 2006 Jul 15;369(1):1-16. (PMID: 16469304) Diabetes. 1988 Dec;37(12):1595-607. (PMID: 3056758) Hypertension. 1993 May;21(5):618-23. (PMID: 8491496) Nat Rev Immunol. 2003 Jan;3(1):23-35. (PMID: 12511873) Front Biosci. 2008 Jan 01;13:453-61. (PMID: 17981560) Circ Res. 2010 Feb 19;106(3):536-45. (PMID: 20019330) World J Diabetes. 2015 Apr 15;6(3):456-80. (PMID: 25897356) Clin Exp Hypertens A. 1984;6(1-2):43-60. (PMID: 6697560) Physiol Behav. 2000 Oct 1-15;71(1-2):173-81. (PMID: 11134699) Hypertension. 1999 Oct;34(4 Pt 2):724-8. (PMID: 10523349) Am J Hypertens. 1995 Dec;8(12 Pt 2):100s-105s. (PMID: 8845091) Circ Res. 2001 Feb 2;88(2):E14-22. (PMID: 11157681) Eur J Endocrinol. 2003 Aug;149(2):129-35. (PMID: 12887290) Auton Neurosci. 2014 Jul;183:23-9. (PMID: 24560525) Diabetes Metab. 2000 May;26(3):178-82. (PMID: 10880890) Horm Mol Biol Clin Investig. 2014 Apr;18(1):3-14. (PMID: 25389996) |
| فهرسة مساهمة: | Keywords: cardiovascular diseases; central nervous system; hypertension; insulin resistance; obesity |
| تواريخ الأحداث: | Date Created: 20150918 Date Completed: 20150918 Latest Revision: 20210526 |
| رمز التحديث: | 20240628 |
| مُعرف محوري في PubMed: | PMC4548210 |
| DOI: | 10.3389/fphys.2015.00234 |
| PMID: | 26379553 |
| قاعدة البيانات: | MEDLINE |
Full Text Finder | تدمد: | 1664-042X |
|---|---|
| DOI: | 10.3389/fphys.2015.00234 |